Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Previous GERD history: Any history of acid reflux, hiatal hernia, or esophageal issues before starting tirzepatide
Traditional filamentation assays rely on manual scoring, which is time-consuming, subjective, and difficult to scale
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet licensed by the MHRA or EMA for use in the UK
Semaglutide provides GLP-1 receptor activation (though not the GIP component that tirzepatide offers) and is available in potentially more affordable compounded forms
Check which tier the drug is in, as this dictates your copay
US$ 26.00
&srotate=0)
US$ 24.44
US$ 24.90
